Winiewska-Szajewska M, Poznanski J
Biophys Rev. 2025; 17(1):199-223.
PMID: 40060009
PMC: 11885780.
DOI: 10.1007/s12551-025-01280-3.
Cohrs M, Davy A, Van Ackere M, De Smedt S, Braeckmans K, Epe M
Mol Pharm. 2025; 22(3):1697-1706.
PMID: 39919837
PMC: 11881137.
DOI: 10.1021/acs.molpharmaceut.4c01496.
Vercruysse T, Vanstreels E, Jacquemyn M, Boland S, Kilonda A, Allasia S
Commun Biol. 2024; 7(1):1560.
PMID: 39580542
PMC: 11585640.
DOI: 10.1038/s42003-024-07237-8.
Giannakou M, Akrani I, Tsoka A, Myrianthopoulos V, Mikros E, Vorgias C
Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39458929
PMC: 11510448.
DOI: 10.3390/ph17101286.
Khan M, Rahman M, Xin Y, Mustafa A, Smith B, Ottemann K
ACS Pharmacol Transl Sci. 2024; 7(10):3096-3107.
PMID: 39430314
PMC: 11487536.
DOI: 10.1021/acsptsci.4c00293.
Streamlined analysis of drug targets by proteome integral solubility alteration indicates organ-specific engagement.
Batth T, Locard-Paulet M, Doncheva N, Lopez Mendez B, Jensen L, Olsen J
Nat Commun. 2024; 15(1):8923.
PMID: 39414818
PMC: 11484808.
DOI: 10.1038/s41467-024-53240-2.
Boosting Fructosyl Transferase's Thermostability and Catalytic Performance for Highly Efficient Fructooligosaccharides (FOS) Production.
Niu D, Zhao N, Wang J, Mchunu N, Permaul K, Singh S
Foods. 2024; 13(18).
PMID: 39335925
PMC: 11431173.
DOI: 10.3390/foods13182997.
Identification of Rocaglate Acyl Sulfamides as Selective Inhibitors of Glioblastoma Stem Cells.
Wang Z, Thakare R, Chitale S, Mishra A, Goldstein S, Fan A
ACS Cent Sci. 2024; 10(8):1640-1656.
PMID: 39220711
PMC: 11363328.
DOI: 10.1021/acscentsci.4c01073.
Utilizing Thermal Shift Assay to Probe Substrate Binding to Selenoprotein O.
Gonzalez A, Sreelatha A
J Vis Exp. 2024; (210).
PMID: 39185898
PMC: 11608410.
DOI: 10.3791/67139.
Design and Synthesis of New GS-6207 Subtypes for Targeting HIV-1 Capsid Protein.
Akther T, McFadden W, Zhang H, Kirby K, Sarafianos S, Wang Z
Int J Mol Sci. 2024; 25(7).
PMID: 38612545
PMC: 11012105.
DOI: 10.3390/ijms25073734.
Fragment-based Drug Discovery Strategy and its Application to the Design of SARS-CoV-2 Main Protease Inhibitor.
Jiang Y, Wu Y, Wang J, Ma Y, Yu H, Wang Z
Curr Med Chem. 2024; 31(38):6204-6226.
PMID: 38529602
DOI: 10.2174/0109298673294251240229070740.
Thermal unfolding methods in drug discovery.
Llowarch P, Usselmann L, Ivanov D, Holdgate G
Biophys Rev (Melville). 2024; 4(2):021305.
PMID: 38510342
PMC: 10903397.
DOI: 10.1063/5.0144141.
Repurposing of US-FDA-approved drugs as negative modulators of ubiquitin specific protease-7 (USP7).
Zadi S, Javaid S, Atia-Tul-Wahab , Zafar H, Awais M, Maslennikov I
Heliyon. 2024; 10(5):e26345.
PMID: 38468948
PMC: 10925992.
DOI: 10.1016/j.heliyon.2024.e26345.
Target-based drug discovery: Applications of fluorescence techniques in high throughput and fragment-based screening.
Kumar V, Lakshman P, Prasad T, Manjunath K, Bairy S, Vasu A
Heliyon. 2024; 10(1):e23864.
PMID: 38226204
PMC: 10788520.
DOI: 10.1016/j.heliyon.2023.e23864.
Nucleos(t)ide analogs for hepatitis B virus infection differentially regulate the growth factor signaling in hepatocytes.
Shimizu R, Murai K, Tanaka K, Sato Y, Takeda N, Nakasyo S
Hepatol Commun. 2024; 8(1).
PMID: 38180972
PMC: 10781114.
DOI: 10.1097/HC9.0000000000000351.
Use of TSAR, Thermal Shift Analysis in R, to identify Folic Acid as a Molecule that Interacts with HIV-1 Capsid.
Gao X, McFadden W, Wen X, Emanuelli A, Lorson Z, Zheng H
bioRxiv. 2023; .
PMID: 38076946
PMC: 10705415.
DOI: 10.1101/2023.11.29.569293.
Improved in situ characterization of protein complex dynamics at scale with thermal proximity co-aggregation.
Sun S, Zheng Z, Wang J, Li F, He A, Lai K
Nat Commun. 2023; 14(1):7697.
PMID: 38001062
PMC: 10673876.
DOI: 10.1038/s41467-023-43526-2.
Isothermal chemical denaturation assay for monitoring protein stability and inhibitor interactions.
Mahran R, Vello N, Komulainen A, Malakoutikhah M, Harma H, Kopra K
Sci Rep. 2023; 13(1):20066.
PMID: 37973851
PMC: 10654576.
DOI: 10.1038/s41598-023-46720-w.
Quantitative Biochemical Analysis of Deadenylase Enzymes Using Fluorescence and Chemiluminescence-Based Assays.
Airhihen B, Pavanello L, Maryati M, Winkler G
Methods Mol Biol. 2023; 2723:55-68.
PMID: 37824064
DOI: 10.1007/978-1-0716-3481-3_4.
Discovery of a non-covalent ligand for Rpn-13, a therapeutic target for hematological cancers.
Loy C, Muli C, Ali E, Xie D, Ahmed M, Post C
Bioorg Med Chem Lett. 2023; 95:129485.
PMID: 37714498
PMC: 10639113.
DOI: 10.1016/j.bmcl.2023.129485.